Longboard pharmaceuticals to present at the jmp securities 2022 life sciences conference on june 15

San diego, june 07, 2022 (globe newswire) -- longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that kevin lind, longboard's president & ceo, will present at the jmp securities life sciences conference on june 15, 2022, at 3:00pm et, in new york city.
LBPH Ratings Summary
LBPH Quant Ranking